These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6347779)

  • 1. A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control.
    Krzentowski G; Scheen A; Castillo M; Luyckx AS; Lefèbvre PJ
    Diabetologia; 1983 May; 24(5):314-8. PubMed ID: 6347779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion.
    Scheen A; Castillo M; Jandrain B; Krzentowski G; Henrivaux P; Luyckx AS; Lefèbvre PJ
    Diabetes Care; 1984; 7(4):338-42. PubMed ID: 6381007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 2. Marked attenuation of the metabolic deterioration by somatostatin.
    Scheen AJ; Krzentowski G; Castillo M; Lefèbvre PJ; Luyckx AS
    Diabetologia; 1983 May; 24(5):319-25. PubMed ID: 6135635
    [No Abstract]   [Full Text] [Related]  

  • 4. The degree/rapidity of the metabolic deterioration following interruption of a continuous subcutaneous insulin infusion is influenced by the prevailing blood glucose Level.
    Castillo MJ; Scheen AJ; Lefèbvre PJ
    J Clin Endocrinol Metab; 1996 May; 81(5):1975-8. PubMed ID: 8626867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients.
    Scheen AJ; Gillet J; Rosenthaler J; Guiot J; Henrivaux P; Jandrain B; Lefèbvre PJ
    Diabetologia; 1989 Nov; 32(11):801-9. PubMed ID: 2687064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. U-100 insulin gives some protection against metabolic deterioration due to CSII interruption.
    Scheen AJ; Henrivaux P; Jandrain B; Lefèbvre PJ
    Diabetes Care; 1987; 10(6):707-11. PubMed ID: 3322727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance test.
    Yajnik CS; Shelgikar KM; Naik SS; Kanitkar SV; Orskov H; Alberti KG; Hockaday TD
    Diabetes Res Clin Pract; 1992 Feb; 15(2):149-56. PubMed ID: 1563331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion.
    Pickup JC; Viberti GC; Bilous RW; Keen H; Alberti KG; Home PD; Binder C
    Diabetologia; 1982 Mar; 22(3):175-9. PubMed ID: 7042428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
    Orskov L; Alberti KG; Mengel A; Møller N; Pedersen O; Rasmussen O; Seefeldt T; Schmitz O
    Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with type 1 (insulin-dependent) diabetes mellitus.
    Pal BR; Phillips PE; Matthews DR; Dunger DB
    Diabetologia; 1992 Jun; 35(6):542-9. PubMed ID: 1612227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of metabolic alterations by insulin supplements administered either before or after 2-h nocturnal interruption of CSII.
    Scheen AJ; Henrivaux P; Jandrain B; Paolisso G; Lefèbvre PJ
    Diabetes Care; 1987; 10(5):567-72. PubMed ID: 3315513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of exercise-induced hypoglycaemia in type i (insulin-dependent) diabetic patients during maintenance of normoglycaemia by short-term, open-loop insulin infusion.
    Martin MJ; Robbins DC; Bergenstal R; LaGrange B; Rubenstein AH
    Diabetologia; 1982 Oct; 23(4):336-42. PubMed ID: 6754517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of physical activity on metabolic state within a 3-h interruption of continuous subcutaneous insulin infusion in patients with type 1 diabetes.
    Jankovec Z; Krcma M; Gruberova J; Komorousova J; Tomesova J; Zourek M; Rusavy Z
    Diabetes Technol Ther; 2011 Dec; 13(12):1234-9. PubMed ID: 21877927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism.
    Al-Shoumer KA; Ali K; Anyaoku V; Niththyananthan R; Johnston DG
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):171-8. PubMed ID: 8881449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free insulin levels and metabolic effects of meal-time bolus and square-wave intraperitoneal insulin infusion in insulin-dependent diabetic patients.
    Jimenez JT; Walford S; Home PD; Hanning I; Alberti KG
    Diabetologia; 1985 Oct; 28(10):728-33. PubMed ID: 3905470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic and hormonal response to acute normoglycaemia in type 1 (insulin-dependent) diabetes: studies with a glucose controlled insulin infusion system (artificial endocrine pancreas).
    Nosadini R; Noy GA; Nattrass M; Alberti KG; Johnston DG; Home PD; Orskov H
    Diabetologia; 1982 Sep; 23(3):220-8. PubMed ID: 6751902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of insulin and counter-regulatory hormones in the metabolic changes caused by insulin deprivation in diabetic patients].
    Castillo MJ; Scheen AJ; Gualda P; Lefebvre PJ
    Rev Esp Fisiol; 1989 Mar; 45(1):53-9. PubMed ID: 2664924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diurnal plasma profiles of metabolite and hormone concentration in insulin-dependent diabetic patients during conventional insulin treatment and continuous subcutaneous insulin infusion. A controlled study.
    Hermansen K; Møller A; Christensen CK; Christiansen JS; Schmitz O; Orskov H; Alberti KG; Mogensen CE
    Acta Endocrinol (Copenh); 1987 Mar; 114(3):433-9. PubMed ID: 3551432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic consequences of a 6-hour interruption of a continuous subcutaneous insulin infusion pump in insulin-dependent diabetic patients].
    Scheen AJ
    Rev Med Liege; 1987 Nov; 42(21):837-52. PubMed ID: 2892242
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Guerci B; Meyer L; Sallé A; Charrié A; Dousset B; Ziegler O; Drouin P
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2673-8. PubMed ID: 10443658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.